IMPEDIMED LIMITED — Share Issue/Capital Change 2022

Oct 5, 2022

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

IMPEDIMED LIMITED

Announcement Type

New announcement

Date of this announcement

Thursday October 06, 2022

The +securities to be quoted are: Other

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
IPD	ORDINARY FULLY PAID	2,782,077	04/10/2022

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

IMPEDIMED LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ABN

Registration number 65089705144

1.3 ASX issuer code

IPD

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

6/10/2022

Application for quotation of +securities

2 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

==> picture [8 x 8] intentionally omitted <==

Other

2.2 The +securities to be quoted are:

==> picture [8 x 9] intentionally omitted <==

Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS?

==> picture [8 x 8] intentionally omitted <==

No

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

1,330,035 Shares were issued to non-executive directors pursuant to the Non-Executive Director Share Plan for 60% of director fees for the quarter ended 30 September 2022.

870,407 Shares were issued to executives for up to 20% of their FY23 base remuneration for the quarter ended 30 September 2022.

581,635 Shares were issued to executives who elected to receive 20% of their FY22 STIs in the form of IPD shares rather than cash.

2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Application for quotation of +securities

3 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Additional +securities to be quoted in an existing class

ASX +security code and description IPD : ORDINARY FULLY PAID Issue date 4/10/2022 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 2,782,077 Are the +securities being issued for a cash consideration? Yes In what currency is the cash consideration being paid? What is the issue price per +security? AUD - Australian Dollar AUD 0.06600000 Any other information the entity wishes to provide about the +securities to be quoted Shares are being issued in lieu of cash remuneration. Share price is calculated as the 20-day VWAP prior to the date of issue (Allocation Date), being 04 October 2022. The purpose(s) for which the entity is issuing the securities Other Please provide additional details Shares are being issued in lieu of cash remuneration. 1,330,035 Shares were issued to non-executive directors pursuant to the Non-Executive Director Share Plan for 60% of director fees for the quarter ended 30 September 2022. 870,407 Shares were issued to executives for up to 20% of their FY23 base remuneration for the quarter ended 30 September 2022. 581,635 Shares were issued to executives who elected to receive 20% of their FY22 STIs in the form of IPD shares rather than cash.

Application for quotation of +securities

4 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

==> picture [540 x 710] intentionally omitted <==

Application for quotation of +securities

5 / 7

Application for quotation of +securities

Part 4 - Issued capital following quotation

==> picture [21 x 22] intentionally omitted <==

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

	Total number of
ASX +security code and description	+securities on issue
IPD : ORDINARY FULLY PAID	1,782,766,436

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
IPDAAB : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES.	83,161,750
IPDAA : PERFORMANCE RIGHTS	25,357,000

Application for quotation of +securities

6 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No

5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? Yes

5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1

28/10/2020

Application for quotation of +securities

7 / 7